Yulia Celetaria, global pharma director for Aerion’s Healthc’Air, has been recognised for her outstanding contribution to pharmaceutical logistics at the ACE LGG Excellence Ceremony in Liège.

The accolade comes only months after the launch of Healthc’Air in July 2025, underscoring the rapid industry impact of Celetaria’s expertise. Her leadership is credited with driving innovation, embedding sustainability, and delivering tangible value to Aerion’s pharma logistics portfolio.

Healthc’Air has been designed to disrupt traditional pharmaceutical air logistics. Its modular suite – Launch, Advanced, and Trust – provides airlines and GSAs with end-to-end support ranging from auditing, training, and certification to AI-driven digital tools. The platform also prioritises sustainability, with solutions including route optimisation, reusable packaging, and support for Sustainable Aviation Fuel adoption.

As part of Aerion’s broader strategy, Healthc’Air gives airlines access to commercial, technical, and operational expertise without requiring heavy in-house investment. This approach helps carriers strengthen cargo performance, optimise operations, and improve revenue resilience.

Celetaria commented: “Our ambition at Healthc’Air is to go beyond current industry standards. By listening to real market needs and bringing together top experts, we deliver solutions uniting operational excellence, digital innovation, and lasting sustainability.”